Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer-Reference-Cited by-同舟云学术

Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer

Published:2020-01 Issue:1 Volume:77 Page:14-21
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Isaacsson Velho Pedro,Fu Wei,Wang Hao,Mirkheshti Nooshin,Qazi Fahad,Lima Fabiola A.S.,Shaukat Farah,Carducci Michael A.,Denmeade Samuel R.,Paller Channing J.,Markowski Mark C.,Marshall Catherine H.,Eisenberger Mario A.,Antonarakis Emmanuel S.

Funder

U.S. Department of Defense

National Institutes of Health

Publisher

Elsevier BV

Subject

Urology

Reference37 articles.

1. NCCN clinical practice guidelines in oncology—prostate cancer;Mohler;Prostate Cancer,2018

2. Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet;Armstrong;Ann Oncol,2018

3. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer;Wang;Cell,2009

4. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer;Antonarakis;N Engl J Med,2014

5. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway;Neoplasia;2024-11

2. Gene expression signature of castrate resistant prostate cancer;Gene;2024-10

3. Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment;Expert Review of Anticancer Therapy;2024-09-14

4. Endoplasmic Reticulum Membrane Protein Complex Regulates Cancer Stem Cells and is Associated with Sorafenib Resistance in Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-08

5. Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer;Prostate Cancer and Prostatic Diseases;2024-07-17